Literature DB >> 29579198

A comprehensive evaluation of alignment software for reduced representation bisulfite sequencing data.

Xiwei Sun1, Yi Han1, Liyuan Zhou1, Enguo Chen1, Bingjian Lu2, Yong Liu3, Xiaoqing Pan3, Allen W Cowley3, Mingyu Liang3, Qingbiao Wu4, Yan Lu2, Pengyuan Liu1.   

Abstract

Motivation: The rapid development of next-generation sequencing technology provides an opportunity to study genome-wide DNA methylation at single-base resolution. However, depletion of unmethylated cytosines brings challenges for aligning bisulfite-converted sequencing reads to a large reference. Software tools for aligning methylation reads have not yet been comprehensively evaluated, especially for the widely used reduced representation bisulfite sequencing (RRBS) that involves enrichment for CpG islands (CGIs).
Results: We specially developed a simulator, RRBSsim, for benchmarking analysis of RRBS data. We performed extensive comparison of seven mapping algorithms for methylation analysis in both real and simulated RRBS data. Eighteen lung tumors and matched adjacent tissues were sequenced by the RRBS protocols. Our empirical evaluation found that methylation results were less consistent between software tools for CpG sites with low sequencing depth, medium methylation level, on CGI shores or gene body. These observations were further confirmed by simulations that indicated software tools generally had lower recall of detecting these vulnerable CpG sites and lower precision of estimating methylation levels in these CpG sites. Among the software tools tested, bwa-meth and BS-Seeker2 (bowtie2) are currently our preferred aligners for RRBS data in terms of recall, precision and speed. Existing aligners cannot efficiently handle moderately methylated CpG sites and those CpG sites on CGI shores or gene body. Interpretation of methylation results from these vulnerable CpG sites should be treated with caution. Our study reveals several important features inherent in methylation data, and RRBSsim provides guidance to advance sequence-based methylation data analysis and methodological development. Availability and implementation: RRBSsim is a simulator for benchmarking analysis of RRBS data and its source code is available at https://github.com/xwBio/RRBSsim or https://github.com/xwBio/Docker-RRBSsim. Supplementary information: Supplementary data are available at Bioinformatics online.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29579198     DOI: 10.1093/bioinformatics/bty174

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  10 in total

1.  Benchmarking DNA methylation analysis of 14 alignment algorithms for whole genome bisulfite sequencing in mammals.

Authors:  Wentao Gong; Xiangchun Pan; Dantong Xu; Guanyu Ji; Yifei Wang; Yuhan Tian; Jiali Cai; Jiaqi Li; Zhe Zhang; Xiaolong Yuan
Journal:  Comput Struct Biotechnol J       Date:  2022-08-27       Impact factor: 6.155

2.  Mitochondrial DNA methylation profiling of the human prefrontal cortex and nucleus accumbens: correlations with aging and drug use.

Authors:  Chia-Hung Huang; Man-Chen Chang; Yung-Chun Lai; Chun-Yen Lin; Cho-Hsien Hsu; Bo-Yuan Tseng; Chuhsing Kate Hsiao; Tzu-Pin Lu; Sung-Liang Yu; Sung-Tsang Hsieh; Wei J Chen
Journal:  Clin Epigenetics       Date:  2022-06-25       Impact factor: 7.259

3.  The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia.

Authors:  Mark E Pepin; Concetta Schiano; Marco Miceli; Giuditta Benincasa; Gelsomina Mansueto; Vincenzo Grimaldi; Andrea Soricelli; Adam R Wende; Claudio Napoli
Journal:  Exp Cell Res       Date:  2021-01-27       Impact factor: 3.905

Review 4.  Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience.

Authors:  Mark K Santillan; Richard C Becker; David A Calhoun; Allen W Cowley; Joseph T Flynn; Justin L Grobe; Theodore A Kotchen; Daniel T Lackland; Kimberly K Leslie; Mingyu Liang; David L Mattson; Kevin E Meyers; Mark M Mitsnefes; Paul M Muntner; Gary L Pierce; Jennifer S Pollock; Curt D Sigmund; Stephen J Thomas; Elaine M Urbina; Srividya Kidambi
Journal:  Hypertension       Date:  2021-05-03       Impact factor: 9.897

5.  Differential DNA Methylation Encodes Proliferation and Senescence Programs in Human Adipose-Derived Mesenchymal Stem Cells.

Authors:  Mark E Pepin; Teresa Infante; Giuditta Benincasa; Concetta Schiano; Marco Miceli; Simona Ceccarelli; Francesca Megiorni; Eleni Anastasiadou; Giovanni Della Valle; Gerardo Fatone; Mario Faenza; Ludovico Docimo; Giovanni F Nicoletti; Cinzia Marchese; Adam R Wende; Claudio Napoli
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

Review 6.  Cell-Free DNA Methylation Profiling Analysis-Technologies and Bioinformatics.

Authors:  Jinyong Huang; Liang Wang
Journal:  Cancers (Basel)       Date:  2019-11-06       Impact factor: 6.639

7.  Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer.

Authors:  Shuying Sun; Austin Zane; Carolyn Fulton; Jasmine Philipoom
Journal:  BMC Cancer       Date:  2021-03-12       Impact factor: 4.430

8.  Blood DNA Methylation Predicts Diabetic Kidney Disease Progression in High Fat Diet-Fed Mice.

Authors:  Long T Nguyen; Benjamin P Larkin; Rosy Wang; Alen Faiz; Carol A Pollock; Sonia Saad
Journal:  Nutrients       Date:  2022-02-13       Impact factor: 5.717

Review 9.  Technology dictates algorithms: recent developments in read alignment.

Authors:  Mohammed Alser; Jeremy Rotman; Onur Mutlu; Serghei Mangul; Dhrithi Deshpande; Kodi Taraszka; Huwenbo Shi; Pelin Icer Baykal; Harry Taegyun Yang; Victor Xue; Sergey Knyazev; Benjamin D Singer; Brunilda Balliu; David Koslicki; Pavel Skums; Alex Zelikovsky; Can Alkan
Journal:  Genome Biol       Date:  2021-08-26       Impact factor: 13.583

Review 10.  DNA methylation data by sequencing: experimental approaches and recommendations for tools and pipelines for data analysis.

Authors:  Ieva Rauluseviciute; Finn Drabløs; Morten Beck Rye
Journal:  Clin Epigenetics       Date:  2019-12-12       Impact factor: 6.551

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.